VCG
Vantage Consulting Group Portfolio holdings
AUM
$5.73M
This Quarter Return
+8.35%
1 Year Return
-33.45%
3 Year Return
-18.66%
5 Year Return
–
10 Year Return
–
AUM
$169M
AUM Growth
+$169M
(-1%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
63.85%
Holding
233
New
20
Increased
47
Reduced
142
Closed
21
Top Buys
| 1 |
ServiceNow
NOW
|
$338K |
| 2 |
IBM
IBM
|
$328K |
| 3 |
Targa Resources
TRGP
|
$274K |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$247K |
| 5 |
Booking.com
BKNG
|
$218K |
Top Sells
| 1 |
Syntax Stratified LargeCap ETF
SSPY
|
$4.74M |
| 2 |
SMDY
Syntax Stratified MidCap ETF
SMDY
|
$509K |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
$378K |
| 4 |
Microsoft
MSFT
|
$325K |
| 5 |
PG&E
PCG
|
$248K |
Sector Composition
| 1 | Healthcare | 34.35% |
| 2 | Consumer Staples | 6.88% |
| 3 | Technology | 6.74% |
| 4 | Consumer Discretionary | 5.78% |
| 5 | Energy | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Best Buy
BBY
$15.7B
| $251K | 0.15% |
3,135
-442
| -12% | -$35.5K |
|
127
Organon & Co
OGN
$2.45B
| $250K | 0.15% |
8,956
+341
| +4% | +$9.52K |
|
128
Viatris
VTRS
$12.3B
| $250K | 0.15% |
22,441
-3,561
| -14% | -$39.6K |
|
129
Seagate
STX
$36.3B
| $249K | 0.15% |
4,742
+780
| +20% | +$41K |
|
130
Brown-Forman Class B
BF.B
$13.8B
| $249K | 0.15% |
3,789
+80
| +2% | +$5.25K |
|
131
Edison International
EIX
$21.5B
| $249K | 0.15% |
3,910
-34
| -0.9% | -$2.16K |
|
132
AT&T
T
$208B
| $247K | 0.15% |
13,442
-2,584
| -16% | -$47.6K |
|
|
CTLT
133
DELISTED
CATALENT, INC.
CTLT
| $247K | 0.15% |
+5,486
| New | +$247K |
|
134
Merck
MRK
$214B
| $247K | 0.15% |
2,225
-718
| -24% | -$79.7K |
|
135
Entergy
ETR
$39B
| $247K | 0.15% |
2,193
-78
| -3% | -$8.78K |
|
136
Constellation Brands
STZ
$26.7B
| $246K | 0.15% |
1,063
-41
| -4% | -$9.5K |
|
|
DISH
137
DELISTED
DISH Network Corp.
DISH
| $246K | 0.15% |
17,529
+3,411
| +24% | +$47.9K |
|
138
Eli Lilly
LLY
$659B
| $245K | 0.14% |
671
-141
| -17% | -$51.6K |
|
139
Goldman Sachs
GS
$221B
| $245K | 0.14% |
713
-90
| -11% | -$30.9K |
|
140
Morgan Stanley
MS
$238B
| $244K | 0.14% |
2,869
-185
| -6% | -$15.7K |
|
141
Johnson & Johnson
JNJ
$429B
| $244K | 0.14% |
1,380
-173
| -11% | -$30.6K |
|
142
Moderna
MRNA
$9.41B
| $243K | 0.14% |
1,351
-460
| -25% | -$82.6K |
|
143
Raymond James Financial
RJF
$33.6B
| $241K | 0.14% |
2,255
-263
| -10% | -$28.1K |
|
144
Keurig Dr Pepper
KDP
$39.3B
| $240K | 0.14% |
6,735
-313
| -4% | -$11.2K |
|
145
AbbVie
ABBV
$374B
| $240K | 0.14% |
1,486
-332
| -18% | -$53.7K |
|
146
Pfizer
PFE
$142B
| $239K | 0.14% |
4,670
-699
| -13% | -$35.8K |
|
147
NetApp
NTAP
$23.1B
| $239K | 0.14% |
3,983
+220
| +6% | +$13.2K |
|
148
Broadcom
AVGO
$1.4T
| $237K | 0.14% |
423
-41
| -9% | -$22.9K |
|
149
Gilead Sciences
GILD
$140B
| $236K | 0.14% |
2,746
-1,193
| -30% | -$102K |
|
150
Incyte
INCY
$16.8B
| $236K | 0.14% |
2,935
-626
| -18% | -$50.3K |
|